跳至主要内容
临床试验/NCT06336044
NCT06336044招募中不适用

"Clinical and Instrumental Evaluation of the Safety and Bio-revitalizing Effect on the Face of the Medical Device 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'"

Taumedika s.r.l.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Safety: no adverse events

研究概览

简要总结

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

详细描述

The patients chosen with facial laxity characteristics, at the first visit will be assessed and will receive the treatment (microinjections) in the cheekbone area, over the lips and in the marionette lines. After 4 weeks the first visit will assess the change of the tissutal structure with non invasive measurements.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all sexes
  • 18 to 70 years
  • non smoker

排除标准

  • Pregnancy
  • alcohol or drugs abuse
  • change of BMI during the study
  • previous facial surgery, implants, permanent treatments
  • sensitivity to the product
  • dermatological difficult frame
  • health weakness
  • treated with anticoagulants, antihistaminics, corticosteroids, antidepressants and other drugs impacting on the results

研究组 & 干预措施

Face treatment

Experimental

Patients treated for face needs with Karisma micro injections

干预措施: Karisma (Device)

Lips treatment

Experimental

Patients treated for face needs with Karisma microinjections

干预措施: Karisma (Device)

结局指标

主要结局

Safety: no adverse events

时间窗: 16 weeks

test the safety of the device evaluating any potential adverse event

Efficacy: change of wrinkles and scars

时间窗: 16 weeks

test the efficacy of the device measuring the skin surface using GAIS (Global Aesthetic Improvement Scale) scale

次要结局

  • Duration of the efficacy(16 weeks)

研究者

发起方
Taumedika s.r.l.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验